logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
M

Mark Frydenberg

monash university

63H-index
404Paper Count
1.6WCitation Count
Published Papers 162
Publication Date
logo
Follow-up of focal therapy treatment: Caveats to current recommendations
errCurrent Urology
IF1.3
err2026-01-01
err0
PREAI
errLim, Kylie Y.; Smith, Julian; Ranasinghe, Weranja; Frydenberg, Mark
errShare
errSave
Oncological safety of testosterone replacement therapy in men with localised prostate cancer: a systematic review of observational studies
errBJU International
IF4.4
err2025-08-01
err0
PREAI
errJordan Santucci; Peter Stapleton; Marlon Perera; Joseph Ischia; Declan Murphy; Damien Bolton; Nathan Lawrentschuk; Mark Frydenberg; Niranjan Sathianathen
errShare
errSave
Spatial transcriptomics mapping of immune cell and TGFβ signalling pathway heterogeneity in testicular germ cell tumours
errAndrology
IF3.4
err2025-07-22
err0
errOAAI
errSarah C. Moody; Daniela Fietz; Benedict Nathaniel; Mark Frydenberg; Ben Tran; Hans-Christian Schuppe; Kate L. Loveland
errShare
errSave
An Online Treatment Decision Aid for Men with Low-risk Prostate Cancer Eligible for Active Surveillance and Their Partners Increases the Uptake of Active Surveillance: The Navigate Randomised Controlled Trial
errEuropean Urology Oncology
IF9.3
err2025-04-12
err0
errOAAI
errPenelope Schofield; Stephen Quinn; Natalie Richards; Alan White; Fiona White; Mark Frydenberg; Suzanne Chambers; Louisa G. Gordon; Robert Alexander (’Frank’) Gardiner; Declan G. Murphy; Matthew J. Roberts; John Yaxley; Nathan Lawrentschuk; Kevin Chu; Jeremy Millar; Jeremy Grummet; Ilona Juraskova
errShare
errSave
Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment
errBJU INTERNATIONAL
IF4.4
err2025-04-01
err0
errOAAI
errde Vos, Ivo I.; Marenghi, Cristina; Badenchini, Fabio; Boeve, Egbert R.; Lozano-Urunuela, Francisco; Graefen, Markus; Rannikko, Antti S.; Staerman, Frederic; Sugimoto, Mikio; Kato, Takuma; Somford, Diederik M.; Frydenberg, Mark; Bangma, Chris H.; Remmers, Sebastiaan; Roobol, Monique J.
errShare
errSave
A multicentre implementation trial of an Artificial Intelligence-driven biomarker to inform Shared decisions for androgen deprivation therapy in men undergoing prostate radiotherapy: the ASTuTE protocol
errBMC CANCER
IF3.4
err2025-02-13
err0
errOAAI
errWegener, Eric; Ng, Michael; Guerrieri, Mario; Showalter, Timothy N.; Leon, Jeremy de; Ramani, Sagar; Dreosti, Marcus; Lim, Tee; Wong, Bradley; Chao, Michael; Hogan, Kathryn; Raman, Avi; Mcclintock, Scott; Foreman, Darren; Brown, Matthew; Mccombie, Stephen; Mcmillan, Kevin; Beattie, Kieran; Frydenberg, Mark; Wong, Lih-Ming; Hayne, Dickon; Yaxley, John; Stricker, Phillip; Martin, Jarad
errShare
errSave
Baseline Nodal Status on 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Intermediate- to High-risk Prostate Cancer Is Prognostic for Treatment Failure: Follow-up of the proPSMA Trial
errEuropean Urology Oncology
IF9.3
err2024-11-29
err0
errOAAI
errMichael S. Hofman; Veeru Kasivisvanathan; Emma Link; James Buteau; Matthew J. Roberts; Roslyn J. Francis; Colin Tang; Ian Vela; Paul Thomas; Natalie Rutherford; Jarad M. Martin; Mark Frydenberg; Ramdave Shakher; Lih-Ming Wong; Kim Taubman; Sze Ting Lee; Edward Hsiao; Paul Roach; Michelle Nottage; Ian Kirkwood
errShare
errSave
Variational Bayes machine learning for risk adjustment of general outcome indicators with examples in urology
errNPJ DIGITAL MEDICINE
IF15.1
err2024-09-14
err0
errOAAI
errKoh, Harvey Jia Wei; Gasevic, Dragan; Rankin, David; Heritier, Stephane; Frydenberg, Mark; Talic, Stella
errShare
errSave
Standardized template for clinical reporting of PSMA PET/CT scans
errEuropean Journal of Nuclear Medicine and Molecular Imaging
IF7.6
err2024-08-15
err1
errOAAI
errEsfahani, Shadi A.; Morris, Michael J.; Sartor, Oliver; Frydenberg, Mark; Fanti, Stefano; Calais, Jeremie; Vapiwala, Neha
errShare
errSave
Cost-utility Analysis of Navigate, a Treatment Decision Aid for Men with Prostate Cancer and Their Partners, in Comparison to Usual Care
errEuropean Urology Oncology
IF9.3
err2024-08-01
err0
PREAI
errDaniel Lindsay; Penelope Schofield; Matthew J. Roberts; John Yaxley; Stephen Quinn; Natalie Richards; Mark Frydenberg; Robert Gardiner; Nathan Lawrentschuk; Ilona Juraskova; Declan G. Murphy; Louisa G. Collins
errShare
errSave
Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer
errJOURNAL OF UROLOGY
IF6.8
err2024-08-01
err8
PREAI
errEmmett, Louise; Papa, Nathan; Hope, Thomas A.; Fendler, Wolfgang; Calais, Jeremie; Burger, Irene; Eiber, Matthias; Barbato, Francesco; Moon, Daniel; Counter, William; John, Nikeith; Xue, Alan; Franklin, Anthony; Thompson, James; Rasiah, Kris; Frydenberg, Mark; Yaxley, John; Buteau, James; Agrawal, Shikha; Ho, Bao; Nguyen, Andrew; Liu, Victor; Lee, Jonathan; Woo, Henry; Hsiao, Edward; Sutherland, Thomas; Perry, Elyse; Stricker, Phillip; Hofman, Michael S.; Kasivisvanathan, Veeru; Roberts, Matthew; Murphy, Declan
errShare
errSave
Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical Registry
errEuropean Urology Oncology
IF9.3
err2024-07-01
err0
errOAAI
errChris Bangma; Paul Doan; Lin Zhu; Sebastiaan Remmers; Daan Nieboer; Jozien Helleman; Monique J. Roobol; Mikio Sugimoto; Byung Ha Chung; Lui Shiong Lee; Mark Frydenberg; Laurence Klotz; Michael Peacock; Antoinette Perry; Anders Bjartell; Antti Rannikko; Mieke Van Hemelrijck; Prokar Dasgupta; Caroline Moore; Bruce J. Trock; Christian Pavlovich; Ewout Steyerberg; Peter Carroll; Kyo Chul Koo; Andrew Hayen; James Thompson
errShare
errSave
Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial
errINTERNATIONAL JOURNAL OF CANCER
IF4.7
err2024-06-19
err3
PREAI
errSee, Andrew W.; Conway, Paul; Frydenberg, Mark; Haxhimolla, Hodo; Costello, Anthony J.; Moon, Daniel; Ruljancich, Paul; Grummet, Jeremy; Pranavan, Ganes; Peters, Justin; Smyth, Lloyd M. L.; Gwini, Stella M.; Mckenzie, Dean P.; Bowden, Patrick
errShare
errSave
Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [ 68 Ga]Ga-PSMA-11 Positron Emission Tomography/ Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer
errEUROPEAN UROLOGY ONCOLOGY
IF9.3
err2024-06-01
err7
errOAAI
errButeau, James P.; Moon, Daniel; Fahey, Michael T.; Roberts, Matthew J.; Thompson, James; Murphy, Declan G.; Papa, Nathan; Mitchell, Catherine; Lourenco, Richard De Abreu; Dhillon, Haryana M.; Kasivisvanathan, Veeru; Francis, Roslyn J.; Stricker, Phillip; Agrawal, Shihka; O'Brien, Jonathan; Mcvey, Aoife; Sharma, Gaurav; Levy, Sidney; Ayati, Narjess; Nguyen, Andrew; Lee, Su-Faye; Pattison, David A.; Sivaratnam, Dinesh; Frydenberg, Mark; Du, Yang; Titus, Jehan; Lee, Sze -Ting; Ischia, Joseph; Jack, Greg; Hofman, Michael S.; Emmett, Louise
errShare
errSave
Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database
errJOURNAL OF NUCLEAR MEDICINE
IF9.1
err2023-11-30
err7
errOAAI
errEmmett, Louise; Papa, Nathan; Counter, William; Calais, Jeremie; Barbato, Francesco; Burger, Irene; Eiber, Matthias; Roberts, Matthew J.; Agrawal, Shikha; Franklin, Anthony; Xue, Alan; Rasiah, Krishan; John, Nikeith; Moon, Daniel; Frydenberg, Mark; Yaxley, John; Stricker, Phillip; Wong, Keith; Coughlin, Geoff; Gianduzzo, Troy; Kua, Boon; Ho, Bao; Nguyen, Andrew; Liu, Victor; Lee, Jonathan; Hsiao, Edward; Sutherland, Tom; Perry, Elisa; Fendler, Wolfgang P.; Hope, Thomas A.
errShare
errSave
Effects of enzalutamide on overall survival plus /- early docetaxel in participants aged less than 70 yrs versus greater than or equal to 70 yrs in ENZAMET (ANZUP 1304)
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err0
errOAAI
errHorvath, L. G.; Davis, I. D.; Martin, A.; Zielinski, R.; Thomson, A.; Tan, T. H.; Sandhu, S. K.; Reaume, M. N.; Pook, D.; Parnis, F.; North, S.; Marx, G. M.; McCaffrey, J. A.; McDermott, R. S.; Lawrence, N.; Frydenberg, M.; Chowdhury, S.; Chi, K. N. N.; Stockler, M. R.; Sweeney, C.
errShare
errSave
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi- institutional Study
errEUROPEAN UROLOGY FOCUS
IF5.6
err2023-07-01
err10
errOAAI
errZattoni, Fabio; Marra, Giancarlo; Martini, Alberto; Kasivisvanathan, Veeru; Grummet, Jeremy; Harkin, Timothy; Ploussard, Guillaume; Olivier, Jonathan; Chiu, Peter K.; Valerio, Massimo; Marquis, Alessandro; Gontero, Paolo; Guo, Hongqian; Zhuang, Junlong; Frydenberg, Mark; Moon, Daniel; Morlacco, Alessandro; Kretschmer, Alexander; Barletta, Francesco; Heidegger, Isabel; Tilki, Derya; van den Bergh, Roderick; Dal Moro, Fabrizio; Briganti, Alberto; Montorsi, Francesco; Novara, Giacomo; Gandaglia, Giorgio
errShare
errSave
A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy
errEUROPEAN UROLOGY OPEN SCIENCE
IF4.5
err2023-07-01
err8
errOAAI
errKelly, Brian D.; Ptasznik, Gideon; Roberts, Matthew J.; Doan, Paul; Stricker, Phillip; Thompson, James; Buteau, James; Chen, Kenneth; Alghazo, Omar; O'Brien, Jonathan S.; Hofman, Michael S.; Frydenberg, Mark; Lawrentschuk, Nathan; Lundon, Dara; Murphy, Declan G.; Emmett, Louise; Moon, Daniel
errShare
errSave
Treatment de-intensification for low-risk biochemical recurrence after radical prostatectomy: rational or risky?
errBJU INTERNATIONAL
IF4.4
err2023-06-11
err2
PREAI
errRoberts, Matthew J.; Hruby, George; Kneebone, Andrew; Martin, Jarad M.; Williams, Scott G.; Frydenberg, Mark; Murphy, Declan G.; Namdarian, Ben; Yaxley, John W.; Hofman, Michael S.; Davis, Ian D.; Emmett, Louise
errShare
errSave
Can 68Ga-PSMA positron emission tomography and multiparametric MRI guide treatment for biochemical recurrence after radical prostatectomy?
errBJU INTERNATIONAL
IF4.4
err2023-05-16
err4
errOAAI
errKhanna, Yash; Chinni, Vidyasagar; Gnanasambantham, Kavitha; O'Sullivan, Richard; Ballok, Zita E. E.; Ryan, Andrew; Ramdave, Shakher; Sivaratnam, Dinesh; Bowden, Patrick; Guerrieri, Mario; Ranasinghe, Weranja K. B.; Frydenberg, Mark
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
M
Mark A. Rubin
H-index: 186 · Papers: 1.5K
E
Ewout W. Steyerberg
H-index: 176 · Papers: 1.9K
H
Howard I. Scher
H-index: 164 · Papers: 1.4K
G
Graham G. Giles
H-index: 164 · Papers: 2.4K
J
Johann S. de Bono
H-index: 160 · Papers: 2.5K
View more